ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
28
|
3.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
28
|
3.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
The DEP-Gemcitabine trial cancellation
|
|
sarge17
|
2 |
921 |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
2
|
921
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
28
|
3.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
28
|
3.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
28
|
3.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Unloved at the moment
|
|
sarge17
|
26 |
6.0K |
3 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
26
|
6.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Webinar something pending
|
|
sarge17
|
28 |
3.9K |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
28
|
3.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AZD0466 Clinical Data Presented by AstraZeneca EHA Congress
|
|
sarge17
|
79 |
19K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
79
|
19K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.8K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma completes oversubscribed A$45M placement
|
|
sarge17
|
43 |
17K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
43
|
17K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Mirrabooka creeps up the list of top 20 holders in Starpharma
|
|
sarge17
|
43 |
13K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
43
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.6K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
24
|
4.9K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
52
|
9.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
52
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.8K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
24
|
4.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Can Starpharma mop up 10% of it's shares
|
|
sarge17
|
2 |
476 |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2
|
476
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
9.1K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.7K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.7K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.7K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.7K |
1 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
7
|
1.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.7K |
1 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
29
|
5.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to cry?
|
|
sarge17
|
4 |
1.1K |
2 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.6K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to cry?
|
|
sarge17
|
4 |
1.1K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
SPL |
Is it finally time to cry?
|
|
sarge17
|
4 |
1.1K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.6K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.7K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
29
|
5.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Vulture Capitalists
|
|
sarge17
|
11 |
2.2K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
2.2K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.7K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
1.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.7K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
1.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.9K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
24
|
4.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
sarge17
|
451 |
139K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
451
|
139K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Fundamental Shafting
|
|
sarge17
|
6 |
1.6K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
6
|
1.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.4K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
29
|
5.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.4K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
29
|
5.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.4K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.4K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
29
|
5.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.8K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.8K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|